Search research articles
Contact Us
Filters
Showing results (141-150 of 151) with videos related to
Page
of 16
Sort By:
Nature Medicine
|
June 24, 2018
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis
Luigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
ESMO Open
|
January 4, 2025
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
E Agostinetto, G Pfeiler, D Hlauschek, et al.
ESMO Open
|
October 1, 2024
Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study
Á Guerrero-Zotano, J M Pérez-García, M Ruiz-Borrego, et al.
American Journal of Respiratory Cell and Molecular Biology
|
October 17, 2022
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis
Marilena Pariano, Matteo Puccetti, Claudia Stincardini, et al.
Infection and Immunity
|
March 30, 2021
Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic Patients
Claudio Costantini, Emilia Nunzi, Angelica Spolzino, et al.
Breast Cancer Research and Treatment
|
April 1, 2024
First-line therapy with palbociclib in patients with advanced HR<sup>+</sup>/HER2<sup>-</sup> breast cancer: The real-life study PALBOSPAIN
N Martínez-Jañez, M Bellet Ezquerra, L M Manso Sanchez, et al.
The Journal of Clinical Investigation
|
November 30, 2021
Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy
Frank L van de Veerdonk, Giorgia Renga, Marilena Pariano, et al.
Breast Cancer Research : BCR
|
January 24, 2025
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
A DeMichele, A C Dueck, D Hlauschek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
S J Luen, G Viale, S Nik-Zainal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)
E L Mayer, D Hlauschek, M Gnant, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 151) with videos related to
Sort By:
Page
of 16
Nature Medicine
|
June 24, 2018
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis
Luigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
ESMO Open
|
January 4, 2025
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
E Agostinetto, G Pfeiler, D Hlauschek, et al.
ESMO Open
|
October 1, 2024
Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study
Á Guerrero-Zotano, J M Pérez-García, M Ruiz-Borrego, et al.
American Journal of Respiratory Cell and Molecular Biology
|
October 17, 2022
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis
Marilena Pariano, Matteo Puccetti, Claudia Stincardini, et al.
Infection and Immunity
|
March 30, 2021
Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic Patients
Claudio Costantini, Emilia Nunzi, Angelica Spolzino, et al.
Breast Cancer Research and Treatment
|
April 1, 2024
First-line therapy with palbociclib in patients with advanced HR<sup>+</sup>/HER2<sup>-</sup> breast cancer: The real-life study PALBOSPAIN
N Martínez-Jañez, M Bellet Ezquerra, L M Manso Sanchez, et al.
The Journal of Clinical Investigation
|
November 30, 2021
Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy
Frank L van de Veerdonk, Giorgia Renga, Marilena Pariano, et al.
Breast Cancer Research : BCR
|
January 24, 2025
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
A DeMichele, A C Dueck, D Hlauschek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
S J Luen, G Viale, S Nik-Zainal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)
E L Mayer, D Hlauschek, M Gnant, et al.
Page
of 16